Annual MRI and digital mammography effective for screening high-risk women

This article originally appeared here.
Annual MRI, Mammo Effective for Screening High-Risk Women
Annual MRI, Mammo Effective for Screening High-Risk Women

(HealthDay News) -- Initial results indicate that annual magnetic resonance imaging (MRI) and digital mammography can form an effective screening program for women at high risk of breast cancer, according to research published online June 16 in the Journal of Clinical Oncology.

Anna M. Chiarelli, Ph.D., from Cancer Care Ontario in Toronto, and colleagues compared performance measures after assessment with screening results for 2,207 women with initial screening examinations from the Ontario Breast Screening Program. In July 2011, the program was expanded to screen women aged 30 to 69 years at high breast cancer risk with annual MRI and digital mammography.

The researchers found that the recall rate was significantly higher among women who had abnormal MRI alone versus mammogram alone (15.1 versus 6.4 percent). None of the 35 breast cancers detected (16.3 per 1,000) were identified by mammogram alone, while 65.7 percent were detected by MRI alone. Seventy-one percent were detected among women who were known gene mutation carriers. Detection based on mammogram and MRI was associated with highest positive predictive value (12.4 percent).

"Screening with annual MRI combined with mammography has the potential to be effectively implemented into an organized breast screening program for women at high risk for breast cancer," the authors write.

Abstract
Full Text
Editorial

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs